Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Ind-Swift Laboratories Ltd. is a prominent player in the pharmaceutical manufacturing industry, focused on producing high-quality active pharmaceutical ingredients (APIs) and finished drug formulations. The company is involved in the development, production, and distribution of a vast array of pharmaceutical products, catering to both domestic and international markets. Ind-Swift Laboratories has established itself as a reliable supplier in the pharmaceutical sector by emphasizing research and development, innovation, and stringent quality control measures. Its product portfolio includes a variety of therapeutic categories such as cardiovascular, anti-infectives, and central nervous system treatments, among others. Headquartered in India, Ind-Swift Laboratories plays a vital role in enhancing patient care by ensuring the availability of cost-effective medication options. Its significant market presence underscores its commitment to meeting the growing demands of the pharmaceutical industry across various global regions. The company’s strategic focus on sustainable practices and expanding its production capabilities positions it as a key contributor to the healthcare and pharmaceutical supply chain.